Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Background It remains unclear why radiation clinically provides a synergistic effect when combined with immune checkpoint inhibitors such as nivolumab. The purpose of our study was to retrospectively evaluate whether the therapeutic efficacy of nivolumab is improved as a result of a history of radio...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Atsuto Mouri, Yu Miura, Ayako Shiono, Fuyumi Nishihara, Yoshitake Murayama, Shin‐ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
Format: Artigo
Langue:Inglês
Publié: Wiley 2019-04-01
Collection:Thoracic Cancer
Sujets:
Nivolumab
NSCLC
PD‐1
radiotherapy
synergistic effect
Accès en ligne:https://doi.org/10.1111/1759-7714.13044
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires